Stanford Researchers Awarded $18 Million to Develop a Universal Vaccine
Stanford researchers will develop a universal vaccine platform that could protect against viruses such as influenza and COVID-19, in addition to allergens and bacteria that cause pneumonia.
Myths and Facts: Childhood Vaccines (2026)
The efficacy and safety of vaccines are built on decades of rigorous scientific research, extensive clinical testing and continuous safety monitoring.
CDC Issues Recommendations for 2026-2027 Influenza Vaccines
The Centers for Disease Control and Prevention has issues its recommendations for use of the seasonal 2026-2027 influenza (flu) vaccines.
New COVID Vaccines Approved by FDA
Updated COVID-19 vaccines from Moderna, Novavax-Sanofi and Pfizer-BioNTech have been approved by the U.S. Food and Drug Administration.
Cancer Vaccine Plus KEYTRUDA Study Shows Positive Results in Treating Melanoma
A Phase III trial evaluating adjuvant treatment with intismeran autogene in combination with KEYTRUDA (pembrolizumab) showed positive results in treating patients with completely resected stage IIB-IV melanoma.
FDA Approves First mRNA Influenza Vaccine
The U.S. Food and Drug Administration has approved mFLUSIVA (mRNA-1010), a new vaccine against seasonal influenza, for use in all adults 50 years and older.
Nasal DNA Vaccine Protects Against Tuberculosis
Researchers have developed an experimental therapeutic nasal DNA vaccine for tuberculosis.
New HIV Vaccine Could Protect Against Development of HIV Infection and AIDS
Scientists have developed a new HIV vaccine that has the potential to protect humans from developing HIV infection and AIDS.
BCG Vaccine Linked to Changes in Brain Immunity and Alzheimer’s Biomarkers
The Bacillus Calmette-Guérin accine may alter immune activity around the brain and change levels of a protein closely associated with Alzheimer’s disease in older adults without evidence of the condition.
High-Dose Flu Vaccine Significantly Lowers Risk of Developing Alzheimer’s (2026)
A UTHealth study found adults 65 and older had a lower risk of developing Alzheimer’s disease after receiving a high-dose flu vaccine.